IDEAS home Printed from https://ideas.repec.org/a/eur/ejmsjr/577.html
   My bibliography  Save this article

Using Oral Anticoagulant During the Covid-19 Pandemic in Albania

Author

Listed:
  • Aida Dama

    (Department of Pharmacy, Albanian University, Tirana, Albania)

Abstract

The COVID-19 pandemic is a global health situation characterized by a highly infectious respiratory illness caused by the novel coronavirus SARS-CoV-2. From the first burst until nowadays, the virus had a significant impact on global public health and economies, leading to widespread lockdowns, disruptions to daily life, and a significant number of hospitalizations and deaths. Therapy for COVID-19 primarily involved supportive care, such as supplemental oxygen and hydration, to help alleviate symptoms and prevent complications. Antiviral medications, such as remdesivir, and corticosteroids, such as dexamethasone were also used. With the advancing of the disease, it was seen that the disease attacked the blood vessels and clot formation was a major deadly side effect of the virus. The usage of anticoagulants became priority as they could help in reducing of the risk of thrombosis and other complications associated with the virus. In this study we present a brief summary regarding increase in the usage of oral anticoagulants’ usage among Albanian population in a time slot of four years. The new virus was strongly associated and characterized with clot manifestation in the COVID-19 positive patients. The use of anticoagulants in COVID-19 is important because the virus was associated with a higher risk of thrombotic events, including deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke.

Suggested Citation

  • Aida Dama, 2023. "Using Oral Anticoagulant During the Covid-19 Pandemic in Albania," European Journal of Multidisciplinary Studies Articles, Revistia Research and Publishing, vol. 8, July -Dec.
    • Handle: RePEc:eur:ejmsjr:577
    DOI: 10.26417/176ssl30k
    as

    Download full text from publisher

    File URL: https://revistia.com/index.php/ejms/article/view/6946
    Download Restriction: no
    File URL: https://revistia.com/files/articles/ejms_v8_i2_23/Aida.pdf
    Download Restriction: no
    File URL: https://libkey.io/10.26417/176ssl30k?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eur:ejmsjr:577. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Revistia Research and Publishing (email available below). General contact details of provider: https://revistia.com/index.php/ejms .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.